Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches
- PMID: 32730766
- PMCID: PMC9661919
- DOI: 10.1016/S1474-4422(20)30231-3
Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches
Abstract
Insulin is a peptide secreted by the pancreas and plays an important role in the regulation of glucose metabolism in peripheral tissues. Although the role of insulin in the periphery is well understood, less is known about its multifactorial role in the brain. However, emerging evidence from human and animal studies indicate that insulin influences cerebral bioenergetics, enhances synaptic viability and dendritic spine formation, and increases turnover of neurotransmitters, such as dopamine. Insulin also has a role in proteostasis, influencing clearance of the amyloid β peptide and phosphorylation of tau, which are hallmarks of Alzheimer's disease. Insulin also modulates vascular function through effects on vasoreactivity, lipid metabolism, and inflammation. Through these multiple pathways, insulin dysregulation could contribute to neurodegeneration. Thus, new approaches to restore cerebral insulin function that could offer therapeutic benefit to adults with Alzheimer's disease, vascular cognitive impairment, or related disorders are being investigated.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests
We declare no competing interests.
Figures
Comment in
-
The link between type 2 diabetes and dementia: from biomarkers to treatment.Lancet Diabetes Endocrinol. 2020 Sep;8(9):736-738. doi: 10.1016/S2213-8587(20)30267-9. Epub 2020 Jul 30. Lancet Diabetes Endocrinol. 2020. PMID: 32738930 No abstract available.
References
-
- Alzheimer’s Association. 2019 Alzheimer’s disease facts and figures. https://www.alz.org/media/documents/alzheimers-facts-and-figures-2019-r.pdf (assessed July 21, 2020).
-
- Graham WV, Bonito-Oliva A, Sakmar TP. Update on Alzheimer’s disease therapy and prevention strategies. Annu Rev Med 2017; 68: 413–30. - PubMed
-
- Hoyer S, Möller D, Plaschke K. Desensitization of brain insulin receptor. Effect on glucose/energy and related metabolism. J Neural Transm Suppl 1994; 44: 259–68. - PubMed
-
- Hamed SA. Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications. Expert Rev Clin Pharmacol 2017; 10: 409–28. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
